Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY

v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional
Paid-in
Capital
Accumulated
Deficit
Beginning balance (in shares) at Dec. 31, 2022   7,976,980    
Beginning balance at Dec. 31, 2022 $ 121,333 $ 1 $ 300,645 $ (179,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   41,502    
Stock-based compensation 6,361   6,361  
Net loss (23,527)     (23,527)
Ending balance (in shares) at Mar. 31, 2023   8,018,482    
Ending balance at Mar. 31, 2023 104,167 $ 1 307,006 (202,840)
Beginning balance (in shares) at Dec. 31, 2022   7,976,980    
Beginning balance at Dec. 31, 2022 121,333 $ 1 300,645 (179,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (58,461)      
Ending balance (in shares) at Sep. 30, 2023   8,268,639    
Ending balance at Sep. 30, 2023 77,801 $ 1 315,574 (237,774)
Beginning balance (in shares) at Mar. 31, 2023   8,018,482    
Beginning balance at Mar. 31, 2023 104,167 $ 1 307,006 (202,840)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   171,051    
Cash paid for fractional shares from the Reverse Stock Split (in shares)   (552)    
Cash paid for fractional shares from the Reverse Stock Split (3)   (3)  
Stock-based compensation 4,792   4,792  
Net loss (10,676)     (10,676)
Ending balance (in shares) at Jun. 30, 2023   8,188,981    
Ending balance at Jun. 30, 2023 98,280 $ 1 311,795 (213,516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   79,658    
Stock-based compensation 3,779   3,779  
Net loss (24,258)     (24,258)
Ending balance (in shares) at Sep. 30, 2023   8,268,639    
Ending balance at Sep. 30, 2023 $ 77,801 $ 1 315,574 (237,774)
Beginning balance (in shares) at Dec. 31, 2023 8,311,237 8,311,237    
Beginning balance at Dec. 31, 2023 $ 15,273 $ 1 318,600 (303,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   126,305    
Stock-based compensation (670)   (670)  
Net loss (24,050)     (24,050)
Ending balance (in shares) at Mar. 31, 2024   8,437,542    
Ending balance at Mar. 31, 2024 $ (9,447) $ 1 317,930 (327,378)
Beginning balance (in shares) at Dec. 31, 2023 8,311,237 8,311,237    
Beginning balance at Dec. 31, 2023 $ 15,273 $ 1 318,600 (303,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (83,644)      
Ending balance (in shares) at Sep. 30, 2024 8,650,649 8,650,649    
Ending balance at Sep. 30, 2024 $ (65,613) $ 1 321,358 (386,972)
Beginning balance (in shares) at Mar. 31, 2024   8,437,542    
Beginning balance at Mar. 31, 2024 (9,447) $ 1 317,930 (327,378)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   136,707    
Stock-based compensation 1,875   1,875  
Net loss (25,267)     (25,267)
Ending balance (in shares) at Jun. 30, 2024   8,574,249    
Ending balance at Jun. 30, 2024 (32,839) $ 1 319,805 (352,645)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   76,400    
Stock-based compensation 1,553   1,553  
Net loss $ (34,327)     (34,327)
Ending balance (in shares) at Sep. 30, 2024 8,650,649 8,650,649    
Ending balance at Sep. 30, 2024 $ (65,613) $ 1 $ 321,358 $ (386,972)